Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading APRI News...
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.81% | 15.78 | 14.2% | $301.90m | |
| SHPG | Shire PLC Sponsored ADR | -1.11% | 172.98 | 0.4% | $213.79m | |
| PRGO | Perrigo Co. Plc | 0.83% | 75.27 | 6.4% | $143.86m | |
| PRXL | PAREXEL International Corporation | -0.36% | 86.80 | 7.9% | $136.24m | |
| MNK | Mallinckrodt Plc | 2.12% | 46.33 | 17.7% | $126.60m | |
| ALR | Alere Inc. | -0.10% | 50.18 | 2.7% | $93.63m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.43% | 158.80 | 2.2% | $84.49m | |
| UTHR | United Therapeutics Corporation | -0.08% | 131.59 | 13.9% | $76.26m | |
| ENDP | Endo International Plc | 1.63% | 11.84 | 8.9% | $73.99m | |
| PTLA | Portola Pharmaceuticals, Inc. | 46.75% | 56.13 | 8.9% | $69.62m | |
| HZNP | Horizon Pharma plc | -1.22% | 11.73 | 7.6% | $57.17m | |
| AERI | Aerie Pharmaceuticals, Inc. | -0.45% | 54.80 | 8.9% | $55.00m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.32% | 132.29 | 22.1% | $52.53m | |
| MDCO | Medicines Company | 1.18% | 38.60 | 22.3% | $51.68m | |
| CTLT | Catalent Inc | -1.53% | 37.22 | 2.8% | $40.04m |
Company Profile
Apricus Biosciences, Inc. is a pharmaceutical company focus on the development and commercialization of products and product candidates in the areas of specialty urology and rheumatology. The company products include Vitaros and Femprox. It operates through Pharmaceutical segment which designs, and develops pharmaceutical products including those with its NexACT platform. Apricus Biosciences was founded in 1987 and is headquartered in San Diego, CA.,001M70-E